LOXHD1是一种Ewing肉瘤的融合调节抗原
Tatiana Blanchard1, Pouya Faridi2,3,4,5, Chong Xu6
1Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Scientific reports
|April 15, 2025
概括
脂氧酶同质域1 (LOXHD1) 是Ewing肉瘤 (EwS) 免疫治疗的新目标. 在临床前模型中,LOXHD1特异性T细胞根除了EWS瘤,突出了其作为瘤相关抗原的潜力.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- 尤文肉瘤 (EwS) 是一种罕见的儿科癌症,由EWSR1::FLI1融合瘤基因驱动.
- EWSR1::FLI1融合调高异常基因表达,包括脂氧酶同质域1 (LOXHD1).
- LOXHD1的受限表达和在EWS进展中的作用表明它可能成为免疫治疗点.
研究的目的:
- 研究LOXHD1作为EWS免疫疗法的潜在瘤相关抗原 (TAA).
- 为了评估针对LOXHD1.1的T细胞的疗效.
主要方法:
- 鉴定局限于HLA-A*02:01.01的LOXHD1免疫原性表位.
- 对LOXHD1.1.特有的高性αβTCRs的隔离和表征.
- 工程CD8+ T细胞与LOXHD1特异性TCR用于体外和体外测试.
主要成果:
- 特定于LOXHD1的工程 CD8+ T 细胞对HLA-A*02:01+ EwS细胞系表现出细胞毒性活性.
- 这些工程T细胞的采用转移导致了EWS的老鼠异种移植模型中的瘤根除.
- 证实LOXHD1是一种融合调节的,非突变的TAA,在正常组织中表达有限.
结论:
- LOXHD1是EWS免疫疗法的一个有前途的TAA,因为它对融合调节和受限制的表达.
- 基于LOXHD1特异性的T细胞疗法显示了治疗EWS的显著潜力.
- 向LOXHD1为EWS治疗提供了一种新的策略,最大限度地降低了瘤外毒性.
相关概念视频
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
lncRNA - Long Non-coding RNAs
8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K


